Compare Star Bulk Carriers Corp (SBLK) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Star Bulk Carriers Corp vs GeneDx Holdings Corp — how do they compare? Star Bulk Carriers Corp trades at $31.1 (market cap $3.46B), while GeneDx Holdings Corp trades at $86.53 (market cap $2.56B). The key difference: Star Bulk Carriers Corp is the larger of the two by market cap, and Star Bulk Carriers Corp pays a 6.06% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| SBLK | WGS | |
|---|---|---|
Market Cap | $3.46B | $2.56B |
Sector | Industrials | Technology |
52-Week High | $32.42 | $167.51 |
52-Week Low | $16.79 | $34.51 |
Enterprise Value | $4.14B | $2.60B |
Dividend Yield | 6.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Star Bulk Carriers (SBLK) trades at $31.02, down 4.32% on the day, with strong technical indicators showing a bullish trend. The company demonstrates robust fundamentals with Q2 2026 EPS of $1.21 beating expectations by 27%, maintaining a three-quarter earnings beat streak. Valuation metrics appear reasonable with P/E of 12.16 and P/B of 1.38, while profitability remains strong with 23.87% net income margin. Recent developments include a parallel listing on Euronext Athens and consistent dividend payments.
SBLK presents a compelling investment case with strong earnings momentum, attractive dividend yield, and positive analyst sentiment. However, risks include shipping rate volatility and geopolitical tensions affecting global trade. The stock's current technical strength and fundamental performance suggest potential upside, though investors should monitor industry cyclicality and the company's execution on its growth strategy.
WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.
Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
